openPR Logo
Press release

Bowel Management Systems Market 2024-2031 | Exclusive Study Report

04-10-2024 11:06 PM CET | Associations & Organizations

Press release from: ABNewswire

Bowel Management Systems Market

Bowel Management Systems Market

"Bowel Management Systems Market" in terms of revenue was estimated to be worth $2.19 billion in 2023 and is poised to reach $3.02 billion by 2031
"Bowel Management Systems Market" in terms of revenue was estimated to be worth $2.19 billion in 2023 and is poised to reach $3.02 billion by 2031, growing at a CAGR of 4.24% from 2024 to 2031 according to a new report by InsightAce Analytic.

Request for Sample Pages: [https://www.insightaceanalytic.com/request-sample/1422]

Latest Drivers Restraint and Opportunities Market Snapshot:

Key factors influencing the global Bowel Management Systems market are:

* Favorable reimbursement policies
* Prevalence of chronic bowel disorders
* Increasing geriatric population

The following are the primary obstacles to the Bowel Management Systems market's expansion:

* Underreporting of fecal incontinence (FI)
* A patient inclination for non-invasive clinical management of fecal incontinence (FI)
* Limited reimbursement coverage

Future expansion opportunities for the global Bowel Management Systems market include:

* Increasing home healthcare market
* Strategic collaborations by market players
* Rising awareness and acceptance of bowel-related disorders

Market Analysis:

The rising prevalence of chronic bowel disorders such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and chronic constipation is increasing the market demand. Technological advancements in bowel management devices, including developing innovative and minimally invasive solutions, are also fueling market growth. Furthermore, the growing awareness among patients and healthcare providers, the emergence of home-based care solutions, and personalized treatment approaches present new growth opportunities for market players.

List of Prominent Players in the Bowel Management Systems Market:

* Coloplast Group
* ConvaTec Group, plc.
* Consure Medical
* Hollister Incorporated
* Laborie Medical Technologies, Corp.
* ProSys International Ltd.
* Renew Medical, Inc.
* Welland Medical Limited
* Qufora A/S
* Medtronic
* Wellspect HealthCare
* TG Eakin

Bowel Management Systems Market Report Scope:

Report Attribute

Specifications

Market size value in 2023

USD 2.19 billion

Revenue forecast in 2031

USD 3.02 billion

Growth rate CAGR

CAGR of 4.24% from 2024 to 2031

Quantitative units

Representation of revenue in US$ Million, and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments covered

By Product, Patient Type, End-Use

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Recent Developments:

* In April 2022, Microbiotica secured project funding from the Crohn's and Colitis Foundation through their inflammatory bowel disease ventures program. This funding aims to support the development of therapies specifically designed to treat inflammatory bowel disease.
* In February 2022, Coloplast introduced the SenSura Mio in Singapore, aiming to enhance the quality of life for individuals with ostomies who are managing a stoma.
* In 2019, OstomyCure unveiled the TIES solution and initiated ongoing clinical trials at hospitals in the United Kingdom, Sweden, Poland, and Austria.

Curious about this latest version of the report? @ [https://www.insightaceanalytic.com/enquiry-before-buying/1422]

Bowel Management Systems Market Dynamics:

Market Drivers: Prevalence of Chronic Bowel Disorders

The prevalence of chronic bowel disorders varies geographically and is influenced by factors such as genetics, lifestyle, diet, and environmental factors. Conditions like irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and neurological disorders often require long-term management, creating a sustained demand for bowel management systems. These conditions substantially burden healthcare systems worldwide, leading to increased healthcare utilization, impaired quality of life, and economic costs. Early diagnosis, effective management strategies, and ongoing research into the underlying mechanisms of these disorders are crucial for improving patient outcomes and reducing their impact on individuals and society.

Challenges: Patient Inclination Towards Non-Invasive Clinical Management Of Fecal Incontinence (FI)

Patient inclination towards non-invasive clinical management of FI can pose challenges for the market for bowel management systems, particularly for invasive devices and surgical interventions. Companies operating in this space may need to address patient preferences, cost considerations, regulatory barriers, and educational needs to navigate and grow in this market segment effectively. Furthermore, the market for invasive bowel management systems may be constrained by patients' preference for non-invasive treatments, resulting in a smaller target population willing to consider invasive options. This limited market can hinder the growth and profitability of companies developing and marketing invasive devices.

North America Is Expected To Grow With the Highest CAGR during the Forecast Period

The North American Bowel Management Systems Market is likely to register a significant revenue share and develop at a rapid CAGR soon. This is due to the growing population of older adults in this sector. It is anticipated that the U.S. will maintain its dominant position in the North American market throughout the forecast period. This prevalence is partly attributed to the higher incidence of irritable bowel syndrome (IBS) in this region. For instance, the International Foundation for Gastrointestinal Disorders estimates that between 25 and 45 million Americans are affected by IBS. Moreover, a notable trend in the North American bowel management systems market is the continuous research and development efforts to innovate advanced devices for fecal management. The increasing aging population in this region also contributes to the industry's growth.

Segmentation of Bowel Management Systems Market-

By Product-

* Systems

* Colostomy Bags
* Irrigation Systems
* Sacral Neuromodulation Systems
* Others

* Accessories

* Plugs
* Catheters
* Implants
* Anal Sphincters
* Stool Bags
* Others

By Patient Type-

* Pediatric
* Adult

By End-User-

* Hospitals & Clinics
* Ambulatory Surgical Centers
* Home Care Settings

By Region-

North America-

* The US
* Canada
* Mexico

Europe-

* Germany
* The UK
* France
* Italy
* Spain
* Rest of Europe

Asia-Pacific-

* China
* Japan
* India
* South Korea
* South East Asia
* Rest of Asia Pacific

Latin America-

* Brazil
* Argentina
* Rest of Latin America

Middle East & Africa-

* GCC Countries
* South Africa
* Rest of Middle East and Africa

For More Customization @ [https://www.insightaceanalytic.com/customisation/1422]

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D'Souza
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=bowel-management-systems-market-20242031-exclusive-study-report]
Country: United States
Website: https://www.insightaceanalytic.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bowel Management Systems Market 2024-2031 | Exclusive Study Report here

News-ID: 3459323 • Views:

More Releases from ABNewswire

Houston Primary Care Physician Lisa L. Ehrlich, MD Endorsed for Re-election to the TMA Board of Trustees
Houston Primary Care Physician Lisa L. Ehrlich, MD Endorsed for Re-election to t …
As a trustee, Dr. Ehrlich has put the TMA's mission and vision at the forefront of her efforts to improve the circumstances of the practice of medicine by striving to keep TMA's strength as her top priority. Houston, TX - On 04/24/2024, Harris County Medical Society endorses Lisa L. Ehrlich [https://9sm32.r.sp1-brevo.net/mk/mr/sh/1t6AVsd2XFnIGK91b8VL5c5zA4jD6r/IPsLpzLlwj6G], MD, for re-election to the TMA Board of Trustees. It has been said that these are "unprecedented times." Such times require
Houston Natural Resources (OTC: HNRC) Strengthens Global Energy Market Presence
Houston Natural Resources (OTC: HNRC) Strengthens Global Energy Market Presence
Houston Natural Resources Corporation (OTC: HNRC) stands out as a leading entity in the oil and gas industry, marked by strategic acquisitions such as Cunningham Energy, investments in HNR Acquisition Corp. (NYSE: HNRA) and a notable stake in Rhino Energy, highlighting its expansion and growing influence globally. Particularly notable is its significant progress over the past year. While the company is branching into alternative energy, it remains a central player
Stocks on The Street Under 10 in Focus: FFIE, SPZI, HNRC, PEGY, HALB
Stocks on The Street Under 10 in Focus: FFIE, SPZI, HNRC, PEGY, HALB
It is crucial for investors to diligently research to identify stocks worth monitoring. Given the vast array of stocks available, this task can often be challenging. This overview delves into five stocks that might be worth watching currently. Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE), a global leader in the shared intelligent electric mobility ecosystem based in California, disclosed receiving a non-compliance notification from The NASDAQ Stock Market LLC, dated April
Oncolytic Virus Cancer Therapy Pipeline Outlook, FDA Approvals, Clinical Trials and Companies 2024
Oncolytic Virus Cancer Therapy Pipeline Outlook, FDA Approvals, Clinical Trials …
DelveInsight's, "Oncolytic Virus Cancer Therapy Pipeline Insight 2024" report provides comprehensive insights about 120+ companies and 125+ pipeline drugs in Oncolytic Virus Cancer Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Oncolytic Virus Cancer

All 5 Releases


More Releases for Bowel

Bowel Irrigation Systems Market Forecast 2022-2030
Owing to the surging geriatric population facing bowel management issues, and advancements in bowel irrigation systems, the global bowel irrigation systems market is expected to record a market value of US$ 331.2 Mn in 2022, and is further expected to expand at a CAGR of 2.7% over the forecast period (2022-2032). Fecal incontinence is one of the most common bowel management issues in the elderly population, which is responsible for other
Global Bowel Irrigation System Market - Forecasts to 2026
According to a new market research report published by Global Market Estimates, the Global Bowel Irrigation System Market is projected to grow from USD 248.68 million in 2021 to USD 291.10 million by 2026 at a CAGR value of 3.2% between 2021 to 2026. The market will develop steadily owing to the rising prevalence of colorectal cancer and chronic bowel syndrome, the minimally intrusive aspect of treatment, and technical improvements. Browse
Inflammatory Bowel Disease Market: The Present and Future of Inflammatory Bowel …
Stratagem Market Insights have included the latest addition of a global market research report titled Inflammatory Bowel Disease Market tits expansive repository. The report studies primary and secondary research in order to analyze the data effectively. The market study further draws attention to crucial industry factors such as global clients, potential customers, and sellers, which instigates positive company growth. In order to gauge the turning point of the businesses, significant
Irritable Bowel Syndrome (IBS) Treatment Market: Increasing Prevalence of Irrita …
The major factors such as the increasing prevalence of irritable bowel syndrome diseases and rising research & development activities drive the market growth. However, the limited number of product availability and treatment inefficiency restrain the market growth. IBS is a common chronic condition that affects the abdominal organ, large intestine. It is also known as spastic colon, mucous colitis, irritable colon, and spastic colitis. The condition is much different than
Short Bowel Syndrome Market Short Bowel Syndrome Market Size, Share And Top Comp …
Coherent Market Insights has announced the addition of the “Short Bowel Syndrome Market Size Status and Forecast 2026”, The report classifies the global Short Bowel Syndrome Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Short Bowel Syndrome Market Speaker market, analyzes and researches the Short Bowel Syndrome Market Speaker development status and forecast
Digital Landscape: Inflammatory Bowel Disease Market
The Digital Landscape Inflammatory Bowel Disease market report analyzes digital activities undertaken by pharma in support of disease-modifying therapies for mild-to-moderate, and moderate-to-severe Crohn’s disease and ulcerative colitis (UC). Key Highlights - US Patients: AbbVie offers the strongest support for IBD patients in the US, particularly branded, unbranded and mobile app. Janssen was the most active competitor in the branded and social media spaces in 2017. Branded activity also seen from pipeline